Domagala et al. have claimed that 18% of BRCA1-associated cancers have low or no nuclear expression of PARP1 [32] and low PARP1 expression in 21% of triple-negative BRCA1-associated breast cancers [33]. This evidence concerns the gene BRCA1 and breast cancer.